Previous studies have reported that FOXM1 is overexpressed in various cancers and sarcomas including breast cancer, melanoma, angiosarcoma, lung cancer, pancreatic cancer, gastric cancer, prostate cancer, leukemia, leiomyosarcoma, and synovial sarcoma 48–59. Here, FOXM1 is linked to cancer.